StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack net income

Net income is the profit left for shareholders after every expense, interest and tax.

Glucotrack's net income for the twelve months ending Jun 30, 2026 was -$15.95M. For fiscal 2025 it was -$19.39M. The highest annual figure on record is $10.33M in fiscal 2017.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$19.39M–
FY2024Dec 31, 2024-$22.60M–
FY2023Dec 31, 2023-$7.10M–
FY2022Dec 31, 2022-$4.44M–
FY2021Dec 31, 2021-$4.07M–
FY2020Dec 31, 2020-$2.70M-176.7%
FY2019Dec 31, 2019$3.52M–
FY2018Dec 31, 2018-$6.72M-165.0%
FY2017Dec 31, 2017$10.33M–
FY2016Dec 31, 2016-$5.41M–
FY2015Dec 31, 2015-$5.84M-296.0%
FY2014Dec 31, 2014$2.98M–
FY2013Dec 31, 2013-$9.80M–
FY2012Dec 31, 2012-$2.77M–
FY2011Dec 31, 2011-$2.36M–
FY2010Dec 31, 2010-$2.79M–
FY2009Dec 31, 2009-$1.20M–
FY2008Dec 31, 2008-$1.53M–
FY2007Dec 31, 2007-$1.59M–
FY2006Dec 31, 2006-$1.28M–
FY2005Dec 31, 2005-$1.06M–
FY2004Dec 31, 2004-$288.23K–
FY2003Dec 31, 2003-$350.29K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.81M–
Q1 FY2026Mar 31, 2026-$4.33M–
Q4 FY2025Dec 31, 2025-$3.63M–
Q3 FY2025Sep 30, 2025-$4.17M–
Q2 FY2025Jun 30, 2025-$4.76M–
Q1 FY2025Mar 31, 2025-$6.83M–
Q4 FY2024Dec 31, 2024-$10.09M–
Q3 FY2024Sep 30, 2024-$5.09M–
Q2 FY2024Jun 30, 2024-$4.49M–
Q1 FY2024Mar 31, 2024-$2.93M–
Q4 FY2023Dec 31, 2023-$2.41M–
Q3 FY2023Sep 30, 2023-$2.22M–
Q2 FY2023Jun 30, 2023-$1.18M–
Q1 FY2023Mar 31, 2023-$1.29M–
Q4 FY2022Dec 31, 2022-$1.29M–
Q3 FY2022Sep 30, 2022-$928.00K–
Q2 FY2022Jun 30, 2022-$1.13M–
Q1 FY2022Mar 31, 2022-$1.09M–
Q4 FY2021Dec 31, 2021-$1.51M–
Q3 FY2021Sep 30, 2021-$804.00K–
Q2 FY2021Jun 30, 2021-$853.00K–
Q1 FY2021Mar 31, 2021-$904.00K–
Q4 FY2020Dec 31, 2020-$879.00K-113.7%
Q3 FY2020Sep 30, 2020-$509.00K–
Q2 FY2020Jun 30, 2020-$574.00K–
Q1 FY2020Mar 31, 2020-$734.00K–
Q4 FY2019Dec 31, 2019$6.43M–
Q3 FY2019Sep 30, 2019-$996.78K–
Q2 FY2019Jun 30, 2019-$898.86K–
Q1 FY2019Mar 31, 2019-$1.02M-155.3%
Q4 FY2018Dec 31, 2018-$1.33M-107.4%
Q3 FY2018Sep 30, 2018-$1.57M–
Q2 FY2018Jun 30, 2018-$1.96M–
Q1 FY2018Mar 31, 2018$1.85M–
Q4 FY2017Dec 31, 2017$18.00M–
Q3 FY2017Sep 30, 2017-$2.58M–
Q2 FY2017Jun 30, 2017-$2.56M–
Q1 FY2017Mar 31, 2017-$2.53M–
Q4 FY2016Dec 31, 2016-$1.14M–
Q3 FY2016Sep 30, 2016-$1.45M–

More Glucotrack figures

See a number that looks wrong?